Changeflow GovPing Pharma & Drug Safety DEA Diversion Control Division Industry Day on ...
Routine Notice Added Final

DEA Diversion Control Division Industry Day on IT Modernization

Favicon for www.dea.gov DEA Press Releases
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The DEA announced an upcoming Industry Day on March 26, 2026, focused on IT modernization efforts supporting its Diversion Control mission. The event aims to discuss regulatory, legal, compliance, and enforcement missions.

What changed

The Drug Enforcement Administration (DEA) is hosting an Industry Day on March 26, 2026, to discuss IT modernization initiatives related to its Diversion Control Division. The event will cover how technology supports the DEA's regulatory, legal, compliance, and enforcement missions concerning controlled substances.

Industry stakeholders are invited to attend and engage in discussions. Registration was required by 11:59 pm EST on March 24, 2026, via a provided link. This event is informational and does not impose new compliance obligations but offers insight into future technological developments impacting the diversion control landscape.

Source document (simplified)

Post

DEA HQ @DEAHQ Join us for #DEADiversion Control Division Industry Day on 3/26 to learn more about our Diversion Control mission & discuss IT modernization supporting regulatory, legal, compliance, & enforcement missions.

Register today by 11:59 pm EST ow.ly/jLKa50YylOe @TheJusticeDept ALT
8:06 pm ยท 24 Mar 2026
817 Views 25 6 14 1 Read 25 replies


New to X?

Sign up now to get your own personalized timeline! Sign up with Google Sign up with Apple Create account By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Something went wrong. Try reloading. Retry

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
DEA
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Diversion Control
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
IT Modernization Regulatory Compliance

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when DEA Press Releases publishes new changes.

Free. Unsubscribe anytime.